Suscribirse

Is there a benefit for health care workers in testing HIV, HCV and HBV in routine before elective arthroplasty? - 09/05/16

Doi : 10.1016/j.otsr.2016.02.012 
M. Winkelmann a, , J.-N. Sorrentino a, M. Klein b, C. Macke a, P. Mommsen a, S. Brand a, C. Schröter a, C. Krettek a, C. Zeckey a
a Trauma Department, Hannover Medical School, Carl-Neuberg-Straße 1, 30625 Hannover, Germany 
b Department for Orthopedics and Traumatology, Sana Hospital Hameln, Saint-Maur-Platz 1, 31785 Hameln, Germany 

Corresponding author. Tel.: +495115323804; fax: +495115328805.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Introduction

Occupational infection of clinical health care workers with blood-borne viruses (BBVs) like human immunodeficiency virus (HIV), hepatitis B virus (HBV) or hepatitis C virus (HCV) is a current and often emotionally discussed issue. HCV and especially HIV are still stigmatized. The consequence is a broad and maybe irrational fear of professional health care workers being infected occupationally. Therefore, we assessed preoperative screening to: (1) answer whether this can detect not previously diagnosed blood-borne virus infections to a great extent, (2) calculate a cost-benefit ratio to find out, if the screening's potential ability to prevent occupational transmission of BBVs to health care workers faces unjustifiable high costs.

Hypothesis

Preoperative routine screening is limited suitable for enhancement of detecting fomites compared to interview the patient.

Materials and methods

Retrospective cohort study of preoperative screening for HIV, HBV and HCV (HBsAg, anti-HCV and HIV-Ab/Ag-Combination) for every patient who was admitted to the traumatologic department for elective arthroplasty between 01/01/1997 and 31/12/2008.

Results

Among the 1534 patients who underwent elective prosthetic surgery [total hip (879) and knee arthroplasty (508), followed by shoulder, elbow and upper ankle joint], 693 (45.2%) patients were male and 841 (54.8) female. Mean age was 64.2±13.8 years. Screening tests were available for 1373 patients (89.5%). Among all screened patients, we found 21 HCV, 10 HBV and 1 HIV infections. 5 HBV (0.5%) and 7 HCV infections (0.7%) were unknown before. Every newly detected infectious patient occasions screening costs about 7250€. Considering this data, the risk of HCV transmission from an index patient with unknown status of infectiousness to health care worker after percutaneous contact to blood is 0.08 ‰ and of HIV transmission is 0.00054 ‰ in our study population.

Discussion

Routine preoperative screening for BBVs of patients undergoing elective arthroplasty, who were asked for HBV, HCV and HIV, should be reconsidered and is, in times of sparse funds, overpriced.

Level of evidence

IV.

El texto completo de este artículo está disponible en PDF.

Keywords : Arthroplasty, Blood-borne virus, Infection, Screening, HIV, HCV


Esquema


© 2016  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 102 - N° 4

P. 513-516 - juin 2016 Regresar al número
Artículo precedente Artículo precedente
  • Outpatient Latarjet surgery for gleno-humeral instability: Prospective comparative assessment of feasibility and safety
  • Y. Bohu, S. Klouche, A. Gerometta, S. Herman, N. Lefevre
| Artículo siguiente Artículo siguiente
  • Two-stage total hip arthroplasty for complex pelvic abnormalities: Example of hip arthrodesis conversion with concomitant treatment of pelvic and acetabular non-union
  • A. Jacquot, T. Goetzmann, S. Jullion, F. Sirveaux, D. Molé, O. Roche

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.